Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in the rabbit model of shigellosis

Acta Paediatr. 1999 Feb;88(2):161-5. doi: 10.1080/08035259950170321.

Abstract

The protective efficacy of an orally administered heat-killed virulent strain of Shigella flexneri 2a (5 weekly oral doses) was evaluated in 25 rabbits (14 immunized and 11 non-immunized controls) against challenge with the same strain of Shigella using the rabbit model of shigellosis. All 11 non-immunized rabbits developed bloody diarrhoea following challenge and 6 (54%) died. None of the 14 immunized rabbits developed diarrhoea (all had pellet stools) but 3 (21%) died from causes not associated with diarrhoea. Protection from diarrhoea and dysentery following oral immunization with a killed Shigella species was 100% and highly significant. Death following challenge was 2.5-fold higher in the non-immunized group (p = 0.115) but was not significant. These promising results suggest that further studies should be undertaken to develop a killed oral vaccine against shigellosis.

MeSH terms

  • Administration, Oral
  • Animals
  • Diarrhea / immunology
  • Diarrhea / prevention & control
  • Disease Models, Animal*
  • Dysentery, Bacillary / immunology*
  • Dysentery, Bacillary / prevention & control*
  • Male
  • Rabbits
  • Shigella flexneri / immunology*
  • Time Factors
  • Vaccines, Inactivated / immunology*
  • Vaccines, Inactivated / therapeutic use*

Substances

  • Vaccines, Inactivated